Amarin Corp Plc (AMRN)

[KCSVEN]

2-3 bucks and then settle down to 2's until PDUFA confirms.

Theoretically they can still be profitable late next year but Lovaza generic 2015 will be tough, they need to sell to someone that can finish Reduce IT or partner with someone that can sell the drug and take interest burden and hold REDUCE IT at 50% of ownership.

They paid close to AMRN $3 a share for Omthera, with Reduce It likely worth twice that if they want to sell out.

Let's see what management says.

Will keep some for long term, await Reduce IT to play out but will move on with rest. Too bad